Shangha Fosun Pharma

Strides Shasun has announced plans to sell Shasun Pharma to its current management, a provider of contract research and manufacturing services in the UK.

The sale consideration is expected to be approximately $36m and will be completed by September 2016.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Shanghai Fosun Pharma has announced a non-binding proposal to acquire Gland Pharma for a purchase consideration ranging between $1bn and $1.5bn.

The company expects that the acquisition will help develop its drug manufacturing and research and development (R&D) capacity.

Image: Shanghai Fosun Pharma expects that the acquisition will help develop its drug manufacturing and research and development (R&D) capacity. Photo: Courtesy of Shanghai Fosun Pharma.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now